NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next predicted deadline: Oct 17, 2023 (Full proposal)

Later predicted deadlines: Sep 17, 2024 (Letter of inquiry), Oct 17, 2024 (Full proposal)

Grant amount: Unspecified amount

Funding uses: Training / Capacity Building, Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

This Funding Opportunity Announcement (FOA) invites applications to use the NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to generate a large volume of integrated genetic and multi-omics data to facilitate discovery of the molecular mechanisms of heart, lung, blood, and sleep (HLBS) disorders. The overall goal is to transition the program from genetic Map to Mechanism (M2) and to fill knowledge gaps that have not been sufficiently covered by existing TOPMed datasets. No funding will be provided under this FOA. The omics and related phenotypic data will be deposited in a public NIH-designated controlled-access database such as the database for Genotypes and Phenotypes (dbGaP) and NHLBIs BioData Catalyst (BDC).

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.